EP Patent

EP0657548A1 — Amplification of nucleic acids in cells

Assigned to Becton Dickinson and Co · Expires 1995-06-14 · 31y expired

What this patent protects

Strand Displacement Amplification for amplification of nucleic acid target sequences in situ in cells in suspension, on slides or in tissues. Excellent specimen morphology is preserved, and either DNA targets, or RNA targets, or both may be selectively amplified. In situ ampl…

USPTO Abstract

Strand Displacement Amplification for amplification of nucleic acid target sequences in situ in cells in suspension, on slides or in tissues. Excellent specimen morphology is preserved, and either DNA targets, or RNA targets, or both may be selectively amplified. In situ amplification by SDA is comparable with immunochemical techniques, so that both amplification of target sequences and immunological staining can be performed on the same specimen.

Drugs covered by this patent

Patent Metadata

Patent number
EP0657548A1
Jurisdiction
EP
Classification
—
Expires
1995-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Becton Dickinson and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.